Overview
Uterine artery embolization (UAE) is a minimally‑invasive interventional radiology procedure that blocks the blood flow to uterine fibroids (benign smooth‑muscle tumors) by injecting tiny particles into the uterine arteries. The goal is to shrink fibroids, relieve symptoms, and avoid major surgery such as hysterectomy. While UAE is generally safe, the procedure can be followed by a spectrum of short‑ and long‑term complications that may affect quality of life, fertility, or overall health.
Who it affects: Primarily women of reproductive age (30‑50 years) who have symptomatic uterine fibroids, heavy menstrual bleeding, pelvic pain, or bulk‑related symptoms. Approximately 20–30 % of women with fibroids elect UAE as a uterus‑preserving alternative.[1] Mayo Clinic
Prevalence of complications: Serious adverse events occur in < 2 % of cases, while minor side‑effects such as post‑embolization syndrome are reported in up to 30 % of patients.[2] Radiology Society of North America (RSNA)
Symptoms
Complications after UAE can present with a range of symptoms. Below is a comprehensive list grouped by the system involved.
1. Post‑embolization syndrome (most common)
- Fever (≥38 °C): Usually low‑grade, lasting 1–3 days.
- Pain: Cramping or pelvic ache that may radiate to the lower back or thighs.
- Nausea/vomiting: Often secondary to pain or medication.
- Fatigue and malaise: General feeling of being unwell.
2. Gynecologic complications
- Persistent or worsening pelvic pain: May indicate infection, non‑target embolization, or scarring.
- Heavy or prolonged bleeding: Could signal uterine necrosis or inadequate embolization.
- Vaginal discharge (malodorous or purulent): Sign of infection or tissue breakdown.
- Menstrual changes: Amenorrhea, hypomenorrhea, or irregular cycles; occasionally a sign of ovarian failure.
3. Vascular and organ‑specific complications
- Non‑target embolization: Particles travel to the ovaries, bladder, or rectum causing pain, ischemia, or organ dysfunction.
- Uterine necrosis: Rare but severe; presents with severe pain, fever, and foul vaginal discharge.
- Ovarian failure: Premature menopause in 2–5 % of women, especially those >45 years old.
- Pelvic infection (pelvic inflammatory disease): Persistent fever, foul discharge, and elevated white blood count.
4. Reproductive and pregnancy‑related issues
- Infertility or reduced ovarian reserve: May manifest as difficulty conceiving after the procedure.
- Prenatal complications: Higher rates of placenta previa or accreta have been reported in pregnancies after UAE.[3] American College of Obstetricians and Gynecologists (ACOG)
5. Psychological & quality‑of‑life effects
- Depression or anxiety related to chronic pain or menstrual disturbances.
- Body image concerns if large fibroids were causing bulk symptoms.
Causes and Risk Factors
Complications arise from a combination of procedural, patient‑specific, and fibroid‑related factors.
Procedural causes
- Particle size & composition: Too small particles can travel beyond the uterine arteries and affect ovaries or other pelvic organs.
- Technical error: Inadvertent embolization of non‑target vessels (e.g., ovarian artery).
- Incomplete embolization: Residual blood flow may lead to fibroid regrowth or persistent symptoms.
Patient‑related risk factors
- Age > 45 years (higher risk of ovarian insufficiency).
- Pre‑existing pelvic infection or active urinary tract infection.
- Large fibroids (>10 cm) or extensive vascular supply.
- History of allergic reaction to contrast media.
- Smoking (impairs microvascular healing).
Fibroid characteristics
- Submucosal location increases risk of intrauterine infection.
- Highly vascular or pedunculated fibroids may require more aggressive embolization, raising complication rates.
Diagnosis
Timely recognition of complications relies on a combination of history, physical examination, and targeted investigations.
Clinical assessment
- Detailed symptom chronology (onset, severity, aggravating/relieving factors).
- Vital signs (fever, tachycardia, blood pressure).
- Pelvic examination for tenderness, discharge, or signs of infection.
Imaging studies
- Transvaginal ultrasound: First‑line to evaluate fibroid size, necrosis, fluid collections, or retained particles.
- Contrast‑enhanced MRI: Gold standard for detecting non‑target embolization, uterine necrosis, and assessing ovarian reserve.
- CT angiography: Rarely used, but valuable if vascular injury or pelvic bleeding is suspected.
Laboratory tests
- Complete blood count (CBC) – look for leukocytosis.
- C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR) – markers of inflammation/infection.
- Serum β‑hCG – rule out pregnancy if amenorrhea present.
- Hormonal panel (FSH, LH, estradiol, AMH) – assesses ovarian function when menopause is a concern.
Specialist consultation
Gynecologists, interventional radiologists, or reproductive endocrinologists may be involved depending on the complication type.
Treatment Options
Treatment is tailored to the specific complication, its severity, and the patient’s reproductive goals.
1. Post‑embolization syndrome (mild)
- Analgesia: NSAIDs (ibuprofen 400‑600 mg q6‑8h) or acetaminophen; short course of opioids if needed.
- Antipyretics: Acetaminophen or ibuprofen to control fever.
- Hydration & rest: Encourage oral fluids and limited activity for 24‑48 h.
- Usually resolves within 1‑2 weeks without further intervention.
2. Infection or pelvic inflammatory disease
- Broad‑spectrum antibiotics: e.g., ceftriaxone 1 g IV daily + doxycycline 100 mg PO BID for 14 days (adjust per culture).
- Hospital admission: Indicated for high fever, hemodynamic instability, or abscess formation.
- Drainage of any identified collections (percutaneous or surgical) may be required.
3. Non‑target embolization (ovarian, bladder, rectal)
- Supportive care and close monitoring.
- Hormone replacement therapy (HRT) for premature ovarian failure after discussion with a reproductive specialist.
- Urologic or colorectal consultation if organ ischemia leads to functional deficits.
4. Uterine necrosis
- Surgical debridement or hysterectomy: Definitive treatment for extensive necrosis.
- Broad‑spectrum antibiotics and aggressive fluid resuscitation.
- Intensive care support if sepsis develops.
5. Persistent fibroid symptoms
- Repeat imaging to assess embolization completeness.
- Consider secondary interventions: repeat embolization, MRI‑guided focused ultrasound, or surgical myomectomy/hysterectomy.
6. Fertility concerns
- Referral to a reproductive endocrinologist.
- Assisted reproductive technologies (ART) such as IVF may be discussed.
7. Lifestyle & supportive measures
- Balanced diet rich in iron and vitamin C (helps with anemia).
- Regular, low‑impact exercise (walking, yoga) to improve circulation.
- Smoking cessation and limiting alcohol to support vascular healing.
Living with Uterine Artery Embolization Complications
While coping with complications can be challenging, practical strategies can improve daily functioning and emotional wellbeing.
- Pain management plan: Keep a log of pain scores and medication timing; discuss dosage adjustments with your provider.
- Heat therapy: Warm compresses on the lower abdomen for 15‑20 minutes can relieve cramping.
- Menstrual tracking: Use a calendar or an app to note cycle length, flow intensity, and any spotting. Report significant changes promptly.
- Nutrition: Include iron‑rich foods (spinach, lentils, lean red meat) and consider an iron supplement if labs show low ferritin.
- Psychological support: Join support groups (online forums or local meet‑ups) and consider counseling if anxiety or depression arises.
- Follow‑up schedule: Typically 1 month, 3 months, and 6 months post‑procedure, then annually if stable. Keep copies of imaging and lab results.
- Future pregnancy planning: Discuss timing (most clinicians recommend waiting ≥6 months) and obtain pre‑conception counseling.
Prevention
Many complications are preventable through careful patient selection, procedural technique, and post‑procedure care.
Before the procedure
- Comprehensive pre‑operative evaluation (CBC, CRP, ultrasound/MRI) to rule out infection.
- Discuss fertility desires; consider alternative treatments (myomectomy, hormonal therapy) if pregnancy is imminent.
- Stop smoking at least 4 weeks prior; optimize vitamin D and nutrition.
- Allergy testing for iodinated contrast if prior reactions are suspected.
During the procedure
- Use calibrated particles (typically 500‑700 µm) to limit non‑target embolization.
- Real‑time fluoroscopic guidance with careful mapping of uterine and ovarian arterial anatomy.
- Prophylactic antibiotics (single dose cefazolin 1 g IV) for patients with higher infection risk.
After the procedure
- Educate patients on signs of infection, severe pain, or abnormal bleeding.
- Prescribe a short course of NSAIDs and acetaminophen to blunt post‑embolization syndrome.
- Schedule early follow‑up (within 7‑10 days) to assess recovery and intervene early if needed.
Complications of Untreated UAE Complications
If complications are ignored, they can evolve into serious health threats.
- Septic pelvic abscess: May require extensive surgery, prolonged antibiotics, and can be life‑threatening.
- Chronic pelvic pain syndrome: Can lead to opioid dependence and reduced quality of life.
- Premature ovarian insufficiency: Early menopause carries risks of osteoporosis, cardiovascular disease, and emotional distress.
- Uterine necrosis: May necessitate total hysterectomy, eliminating any future fertility.
- Infertility or recurrent pregnancy loss: Affects emotional wellbeing and may require assisted reproduction.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe pelvic or abdominal pain that does not improve with prescribed medication.
- High fever (>38.5 °C or 101.3 °F) lasting more than 24 hours.
- Heavy vaginal bleeding (soaking through a pad every hour) or passage of large clots.
- Foul‑smelling vaginal discharge with accompanying fever or chills.
- Rapid heartbeat (≥120 bpm), dizziness, or fainting.
- Signs of allergic reaction to contrast (hives, swelling of face/lips, difficulty breathing).
Prompt medical attention can prevent progression to sepsis, severe hemorrhage, or organ damage.
References
- Mayo Clinic. “Uterine Artery Embolization (UAE) for Fibroids.” Updated 2023. mayoclinic.org
- Radiology Society of North America (RSNA). “Complications of Uterine Artery Embolization.” 2022. rsna.org
- American College of Obstetricians and Gynecologists. “Practice Bulletin: Management of Fibroids.” 2021. acog.org
- Centers for Disease Control and Prevention. “Uterine Fibroids.” 2024. cdc.gov
- National Institutes of Health. “Uterine Artery Embolization: Clinical Guidelines.” 2023. nih.gov
- Cleveland Clinic. “Post‑Embolization Syndrome and Management.” 2022. clevelandclinic.org